Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

11
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
11
Bacterial Signaling01:30

Bacterial Signaling

33.5K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
33.5K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

22
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
22
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

20
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
20
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

711
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
711
Antibiotic Selection00:57

Antibiotic Selection

54.9K
Overview
54.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulsed Field Ablation Is Associated With Fewer Post-Procedural Pericardial Inflammatory Symptoms Compared With Radiofrequency Ablation.

Journal of cardiovascular electrophysiology·2026
Same author

Impact of pulmonary hypertension on atrial fibrillation recurrence after pulmonary vein isolation: A prospective multicenter registry study.

International journal of cardiology. Heart & vasculature·2026
Same author

Safety and Feasibility of a CT-Based Pathway for Left Atrial Appendage Assessment Prior to Inpatient Cardioversion: A Single-Center Experience.

Clinical cardiology·2026
Same author

Clinical Profile and Mode of Initiation of Spontaneous Ventricular Tachyarrhythmias in Patients With Brugada Syndrome (START-BrS).

JACC. Clinical electrophysiology·2026
Same author

Risk stratification in short QT syndrome: Findings from a pooled analysis.

Heart rhythm·2026
Same author

Class Ic antiarrhythmic drugs and structural heart disease-Time for a randomized controlled study?

Heart rhythm·2026

Related Experiment Video

Updated: Aug 14, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.5K

Regional Antibiotic Delivery for Implanted Cardiovascular Electronic Device Infections.

Moris Topaz1, Ehud Chorin2, Arie Lorin Schwartz2

  • 1Department of Cardiology, Sourasky Tel Aviv Medical Center, Tel Aviv, Israel; Emeritus Plastic Surgery Unit, Hillel Yaffe Medical Center, Hadera, Israel.

Journal of the American College of Cardiology
|January 11, 2023
PubMed
Summary
This summary is machine-generated.

Continuous, in situ-targeted, ultrahigh concentration of antibiotics (CITA) offers a safe and effective alternative for treating pocket infections in patients with cardiovascular implantable electronic devices (pacemakers/defibrillators). This approach avoids device and lead extraction in many cases, reducing complications.

Keywords:
defibrillatorinfectionlead extractionpacemaker

More Related Videos

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

9.9K
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.3K

Related Experiment Videos

Last Updated: Aug 14, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.5K
Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

9.9K
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.3K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Device Technology

Background:

  • Current guidelines recommend complete removal of cardiovascular implantable electronic devices (CIEDs) for localized pocket infections.
  • Device and lead extraction is the standard treatment for CIED pocket infections.

Purpose of the Study:

  • To evaluate the efficacy of continuous, in situ-targeted, ultrahigh concentration of antibiotics (CITA) for treating CIED pocket infections.
  • To determine if CITA can obviate the need for device/lead extraction in patients with CIED pocket infections.

Main Methods:

  • A total of 80 patients with CIED pocket infections were treated with CITA between 2007 and 2021.
  • A case-control study compared CITA treatment with traditional device/lead extraction in 65 and 81 patients, respectively.

Main Results:

  • CITA was curative in 85% of patients, with a median follow-up of 3 years.
  • Device/lead extraction showed higher cure rates (96.2%) than CITA (84.6%), but with significantly more serious complications (14.8% vs 1.5%).
  • All-cause mortality rates at 1 month and 1 year were similar between CITA and device/lead extraction groups.

Conclusions:

  • CITA is a safe and effective alternative treatment for CIED pocket infections, particularly for patients unsuitable or unwilling to undergo extraction.
  • CITA successfully avoided device/lead extraction in 90.8% of eligible patients.
  • This localized antibiotic delivery method presents a viable option for salvaging infected CIEDs.